Dosing regimen of Vinetrog in combination with azacitidine for treatment of myelodysplastic syndrome

The invention described herein relates to therapeutic dosing regimens comprising the administration of vonetog in combination with azacitidine to treat myelodysplastic syndrome (MDS). 本文描述的发明涉及治疗给药方案，其包含与阿扎胞苷联合施用维奈托克以治疗骨髓增生异常综合征(MDS)。...

Full description

Saved in:
Bibliographic Details
Main Authors KAYE STEVEN H, UNSWORTH, WILLIAM, B, HESLIP JAMES
Format Patent
LanguageChinese
English
Published 01.03.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention described herein relates to therapeutic dosing regimens comprising the administration of vonetog in combination with azacitidine to treat myelodysplastic syndrome (MDS). 本文描述的发明涉及治疗给药方案，其包含与阿扎胞苷联合施用维奈托克以治疗骨髓增生异常综合征(MDS)。
Bibliography:Application Number: CN202280048997